Health officials have issued an urgent recall for a popular hair growth treatment containing minoxidil, citing potential safety concerns. The product, sold under the brand name Sefralls, has been pulled from shelves after tests revealed possible risks to consumers.
Why has the product been recalled?
The Medicines and Healthcare products Regulatory Agency (MHRA) announced the recall after quality control tests identified issues with the product's formulation. While minoxidil is an approved treatment for hair loss, the specific formulation in Sefralls may pose health risks when used as directed.
What should consumers do?
If you have purchased this product, you should:
- Stop using it immediately
- Check the batch number against the recall notice
- Return the product to the place of purchase for a full refund
- Consult your GP if you have experienced any adverse effects
Potential health risks
While the exact nature of the safety concern hasn't been specified, minoxidil products can sometimes cause side effects including:
- Scalp irritation
- Unwanted hair growth in other areas
- Dizziness or lightheadedness
- Changes in blood pressure
The MHRA advises anyone who has experienced unusual symptoms after using the product to seek medical advice promptly.
Alternative treatments available
Pharmacists recommend that affected consumers consult with healthcare professionals about alternative hair loss treatments. Many safe and effective minoxidil products remain available on the market that have not been affected by this recall.
The MHRA continues to monitor the situation and will provide updates as more information becomes available. Consumers are urged to check the agency's website for the latest safety announcements.
